Study of Finerenone to Investigate a Paediatric Formulation in Healthy Male Subjects (Q66392493)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Study of Finerenone to Investigate a Paediatric Formulation in Healthy Male Subjects |
clinical trial |
Statements
Relative Bioavailability Study to Investigate the Pharmacokinetics, Safety and Tolerability of a Single Oral Dose of Finerenone 20 mg as Suspension (Pediatric Formulation), Intact Tablet and Crushed Tablet (Adult Formulation) in the Fasting Condition, and to Investigate the Effect of a High Fat, High Calorie Meal on the Suspension in Healthy Male Subjects in a Randomized, Open-label, Four-fold Crossover Design. (English)
0 references
17 November 2016
0 references
13 January 2017
0 references
16
0 references
18 year
0 references
45 year
0 references